Susquehanna Downgrades Warner Chilcott (WCRX) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Leerink Swann Downgrades Warner Chilcott (WCRX) to Market Perform
May 22, 2013 7:03 AM EDTLeerink Swann downgraded Warner Chilcott (NASDAQ: WCRX) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Warner Chilcott click here. For more ratings news on Warner Chilcott click here.
Shares of Warner Chilcott closed at $20.61 yesterday, with a 52 week range of $10.85-$20.64.... More
Warner Chilcott (WCRX) / Actavis (ACT) Deal Features $160M Termination Fee
May 20, 2013 4:56 PM EDTThis Actavis, Inc. (NYSE: ACT) and Warner Chilcott plc (NASDAQ: WCRX) announced they have entered into a definitive agreement under which Actavis will acquire Warner Chilcott plc in a stock-for-stock transaction valued at approximately $8.5 billion. According to filings, the deal has a $160 million termination fee.
From Filing: "The Transaction Agreement contains... More
UPDATE: Lazard Capital Downgrades Warner Chilcott (WCRX), Says Deal Could Fall Through
May 20, 2013 11:01 AM EDT(Updated - May 20, 2013 11:43 AM EDT)
Lazard Capital downgraded Warner Chilcott (NASDAQ: WCRX) from Buy to Neutral. This morning it was learned that Actavis (NYSE: ACT) entered into a definitive agreement under which Actavis will acquire Warner Chilcott in a... More
Valeant (VRX), Mylan (MYL) on Watch as Actavis (ACT) Buys Warner Chilcott (WCRX)
May 20, 2013 7:16 AM EDTValeant Pharmaceuticals (NYSE: VRX) and Mylan (NYSE: MYL), both potential suitors for Actavis, Inc. (NYSE: ACT) are on watch after Actavis announced its own $8.5 billion deal for Warner Chilcott plc (NASDAQ: WCRX) today.... More
Actavis (ACT) to Acquire Warner Chilcott (WCRX) in $8.5B Deal
May 20, 2013 7:08 AM EDTActavis, Inc. (NYSE: ACT) and Warner Chilcott plc (NASDAQ: WCRX) today announced they have entered into a definitive agreement under which Actavis will acquire Warner Chilcott plc in a stock-for-stock transaction valued at approximately $8.5 billion. If successfully completed, the transaction will create a leading global specialty pharmaceutical company with approximately $11 billion in combined annual revenue, and the third-largest U.S. specialty pharmaceutical company with approximately $3 billion in annual revenues focused on core therapeutic categories of Women's Health, Gastroenterology, Urology and Dermatology. The proposed transaction has been unanimously... More
